CD274 and neoplasm: For the 5% cut-off value, PD-L1 positivity in tumor cells (T-PD-L1 (+)) and immune cells (I-PD-L1 (+)) was detected in 33 (23.1%) and 43 (30.1%) of 143 MSI-H GCs, respectively.